Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1985-06-05
1987-07-14
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
540 17, 426 2, A61K 3158, C07J 7100
Patent
active
046802894
ABSTRACT:
Obesity and diabetes obesity syndromes are treated with 5.beta.-sapogenin or .DELTA..sup.5 sapogenin.
REFERENCES:
Merck Index (1976) pp. 439 and 1106.
Fieser et al., "Steroids", (1959) p. 831.
Lipovsky Joseph A.
Progenics, Inc.
Schenkman Leonard
LandOfFree
Treatment of obesity and diabetes using sapogenins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of obesity and diabetes using sapogenins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of obesity and diabetes using sapogenins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1427621